TABLE 3.
Evolution of resistant and non‐resistant hypertensive patients during follow‐up (V1‐V6)
| Visit 0 | Visit 1 | Visit 3 | Visit 6 | P value | |
|---|---|---|---|---|---|
| Evolution of non‐resistant hypertensives (71) | |||||
| Systolic blood pressure—mm Hg (IQR) | 167 (14) | 132 (24) | 128 (17) | 129 (22) | 0.002 |
| Diastolic blood pressure—mm Hg (IQR) | 101 (10) | 85 (14) | 79 (12) | 80 (12) | 0.001 |
| Mean systolic blood pressure a —mm Hg (IQR) | 127 (16) | 124 (11) | 122 (15) | <0.001 | |
| Mean diastolic blood pressure a —mm Hg (IQR) | 78 (12) | 76 (9) | 76 (14) | <0.001 | |
| ADMA ‐ µmol/L (IQR) | 0.55 (0.19) | 0.49 (0.16) | 0.51 (0.11) | <0.001 | |
| Evolution of resistant hypertensives (15) | |||||
| Systolic blood pressure—mm Hg (IQR) | 167 (30) | 177 (18) | 152 (20) | 145 (27) | <0.001 |
| Diastolic blood pressure—mm Hg (IQR) | 112 (27) | 109 (32) | 97 (18) | 92 (16) | <0.001 |
| Mean systolic blood pressure a —mm Hg (IQR) | 162 (34) | 143 (19) | 132 (14) | <0.001 | |
| Mean diastolic blood pressure a —mm Hg (IQR) | 99 (23) | 87 (9) | 83 (14) | <0.001 | |
| ADMA – µmol/L (IQR) | 0.89 (0.34) | 0.79 (0.28) | 0.71 (0.28) | <0.001 | |
Abbreviations: ADMA, asymmetric dimethylarginine; IQR, interquartile range.
a
ABPM: ambulatory blood pressure monitoring,